Regions
Deal focus: CVC gets intimate with A Bathing Ape
CVC Capital Partners has completed a complex carve-out of Japanese streetwear brand A Bathing Ape from diversified Hong Kong retail group I.T
GP profile: Hosen Capital
From renminbi funds to US dollar funds and from growth equity to buyouts, Hosen Capital has been through several evolutions in its first decade. Meeting China’s food needs remains a constant
Carried interest: Safe in Hong Kong?
Tax treatment of carried interest has been an issue of contention in Hong Kong for several years. Just when it seemed to be resolved, draft implementation guidelines are causing disquiet
Fund focus: Unicorn does the hard yards
Six-year-old Unicorn Capital Partners has closed its latest China VC vehicle at the hard cap of $450 million, proving there is demand for fund-of-funds that offer something different
CITIC entities commit $94m to China's Simcere Diagnostics
SimCere Diagnostics, the diagnostics arm of Hong Kong-listed SimCere Pharmaceutical Group, has raised RMB600 million ($94 million) in Series B funding led by CITIC Securities and CITIC Medical & Health Fund.
Blackstone buys International Data Group from China Oceanwide
The Blackstone Group has agreed to acquire International Data Group (IDG) from China Oceanwide Holdings for an enterprise valuation of $1.3 billion.
BGH bids $1b for Australian software provider Hansen
Australian private equity firm BGH Capital has offered to acquired Sydney-listed industrial software provider Hansen Technologies for an enterprise valuation of A$1.3 billion ($1 billion).
India micro VC player Artha raises $30m debut fund
Indian micro VC investor Artha Venture Fund (AVF) has raised INR2.2 billion ($30 million) for its debut vehicle, beating a target of INR2 billion.
China renovation materials trading platform raises $400m
Chubby Bear, a Shanghai-based B2B platform that matches buyers with suppliers of renovation materials, has raised $400 million across two tranches of Series C funding.
Orchid Asia reaches $1.1b first close on Fund VIII
Orchid Asia has achieved a first close of $1.1 billion on its eighth fund, five months after launching the vehicle with a full target of $1.6 billion.
Singapore food tech VC raises $25m for debut fund
Good Startup, a food tech VC set up in Singapore last year, has hit a $25 million first close on its debut fund, which will invest exclusively in alternative protein start-ups.
Primavera buys Reckitt’s China formula business for $2.2b
Primavera Capital Group has agreed to acquire UK-headquartered multinational Reckitt Benckiser’s China infant formula and child nutrition business for an enterprise value of $2.2 billion.
Australia's CPE exits Cell Care to US strategic
Australian middle-market private equity firm CPE has agreed to sell cord blood banking business Cell Care to Generate Life Sciences, a US-based provider of cellular services for fertility and therapeutic purposes.
India's Urban Company closes Series F, hits $2.1b valuation
India’s Urban Company, a marketplace for in-home services from housekeeping to fitness training, has raised $255 million in Series F funding at a valuation of $2.1 billion.
China's Oceanpine raises $312m for renminbi hard-tech fund
Chinese technology and healthcare investor Oceanpine Capital has closed its Hardcore Technology Investment Fund on RMB2 billion ($312 million). LPs include government guidance funds and fund-of-funds in Suzhou, where the new vehicle is based.
Singapore's iGlobe completes $100m fundraise
Singapore-based iGlobe Partners has closed its third venture capital fund with $100 million in commitments.
KV Asia hits $100m first close on Fund II
KV Asia Capital has reached a first close of $100 million for its second Southeast Asia private equity fund. The vehicle, which focuses on the lower middle market, has a target of $300 million.
HarbourVest opens in Singapore, boosts Asia investment team
HarbourVest Partners has expanded its Asia footprint by adding an office in Singapore and strengthened its Hong Kong team with the recruitment of Lydia Hao from Neuberger Berman.
China mRNA specialist Stemirna gets $200m in funding
Stemirna Therapeutics, which claims to be the first biotech company to bring an mRNA therapeutics and nanomedicine platform to China, has raised $200 million in funding.
Unicorn raises $450m for VC fund-of-funds
China-focused venture capital fund-of-funds Unicorn Capital Partners has closed its latest vehicle at the hard cap of $450 million. The process took six months and the fund was oversubscribed
Japan's Dentsu launches second VC fund
Japanese advertising agency Dentsu Group has set up its second corporate VC fund with a corpus of JPY10 billion ($91.1 million).
Singapore's Heritas hits first close on Asia impact fund
Heritas Capital, a Singapore-based private equity firm sponsored by industrial conglomerate IMC Group, has reached a first close of $60 million on a pan-Asia impact investment fund.
TA raises $12.5b for 14th flagship fund
TA Associates, a global growth-oriented investor with a presence in Asia, has closed its 14th flagship fund at the hard cap of $12.5 billion.
L Catterton leads $40m Series B for Singapore's Zenyum
L Catterton has led a $40 million Series B round for Singapore’s Zenyum, a company that makes 3D-printed dental products.